跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,322 条关于
“S1P”
全部
1,322
临床试验
741
药物
470
机构
25
资讯
86
去年
Ozanimod Shows Sustained Reduction in Brain Atrophy in Relapsing Multiple Sclerosis
去年
Priothera Secures €1.7 Million Government Funding to Enhance CAR-T Cell Therapy with Novel S1P Receptor Modulator
5年前
BMS Seeks FDA Approval for Zeposia in Ulcerative Colitis with May Decision Date
去年
Everest Medicines' VELSIPITY® (Etrasimod) Gains Regulatory Traction in Greater China for Ulcerative Colitis Treatment
去年
Cenerimod Demonstrates Reduced Interferon Signatures in Phase 2b SLE Trial
去年
COVID-19 Vaccination in Multiple Sclerosis: Balancing Efficacy and Safety
去年
Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Lead Phase 3 Trial of Mocravimod for Acute Myeloid Leukemia
去年
Taiwan Accepts Everest Medicines' VELSIPITY Application for Ulcerative Colitis Treatment
去年
Hong Kong Approves VELSIPITY® for Moderately to Severely Active Ulcerative Colitis
去年
Everest Medicines Launches VELSIPITY® for Ulcerative Colitis in Greater Bay Area
第 1 页,共 9 页
上一页
下一页